Arjun Pennathur, MD
back

Titles:
Assistant Professor of Surgery (Tenure track)
Heart, Lung, and Esophageal Surgery Institute, Division of Thoracic Surgery

Degrees:

POST GRADUATE EDUCATION
INSTITUTION AND LOCATION
DEGREE YEAR FIELD
Tirunelveli Medical College, Madurai University, Tamilnadu, India MD   Medicine
Residency:  
Massachusetts General Hospital & Harvard Med School, Boston, MA 
University of Nevada
Resident   General Surgery
Fellowship:
 
Johns Hopkins Univ School of Med, Baltimore, MD  Fellow   Surgical Critical Care
University  of Georgia/Vanderbilt University School of Medicine Fellow   Cardio-thoracic Surgery
Board Certifications: Year
American Board of Surgery
1997, 2006

Major Honors/Awards:

  • Career Development Award, NIH
  • NIH Award for Distinguished accomplishments in the biomedical sciences

Current Research Interest:

  • Newer technologies in the treatment of lung neoplasms
  • Proteomics/Genomics in Lung and esophageal neoplasms
  • Signal Transduction mechanisms of Acute Lung Injury

Publications:

  • Pennathur A, Luketich JD, Abbas G, Chen M, Fernando HC, Gooding WE, Schuchert MJ, Gilbert S, Christie NA , Landreneau RJ. Radiofrequency Ablation  for the Treatment of Stage I Non-small Cell Lung Cancer in High-Risk Patients.  J Thoracic Cardiovascular Surgery 134(4):857-64; Oct 2007

  • Keeley. S,  Pennathur, A, Gooding WE,  Landreneau R,  Christie N,  Alvelo-Rivera M, Luketich JD. Using Photodynamic Therapy to cure esophageal cancer and Barrett’s High Grade Dysplasia.  Ann Surg Oncol. 2007 Aug;14(8):2406-10.

  • Pennathur A, Landreneau RJ, Luketich JD. Surgical aspects of the patient with high-grade dysplasia. Seminars in Thoracic & Cardiovascular Surgery.17(4):326-32, 2005.

  • Pennathur A, Luketich JD, Burton S, Abbas G,  Heron DE et al. Stereotactic Radiosurgery for the Treatment of Lung Neoplasm: Initial  Experience. Annals of Thoracic Surgery, 2007 May;83(5):1820-4; discussion 1824-5

  • Parinandi NL, Kleinberg MA,  Usatyuk PV,  Cummings RJ, Pennathur A, Cardounel AJ, Zweier JL, Garcia JGN, and Natarajan V. Hyperoxia-induced NAD[P]H oxidase activation) and regulation by MAP kinases in human lung endothelial cells. Am J Physiology Lung Cellular and Molecular Physiology 2003, 284(1): L26 - 38

  • Anstadt MP, Franga DL,  Portik-Dobos V, Pennathur A, Bannan M, Mawulawde K, Ergul A. Native Matrix Metalloproteinase Characteristics May Influence Early Stenosis of Venous Versus Arterial Coronary Artery Bypass Grafting Conduits Chest 2004;125: 1853 - 1858.

Presentations at Major Meetings:

  • Pennathur A, Luketich JD, Alvelo-Rivera M et al. Long Term Results of a Phase II Trial of Neoadjuvant Chemotherapy Followed by Esophagectomy for Locally Advanced Esophageal Neoplasm.  Presented (Oral Presentation) at Society of Thoracic Surgeons
    Annual Meeting, San Diego, CA Jan 2007

  • Pennathur A, Chang AC, McGrath KM et al. Polyflex Expandable Stents in the Treatment of Esophageal Disease. Presented (Oral  Presentation) at Society of Thoracic Surgeons Annual Meeting, San Diego, CA Jan 2007

  • Awais O, Tam J, Irshad K, Pennathur A, Landreneau RJ, Luketich JD. Roux-en-Y Near Esophagojejunostomy for Intractable Gastroesophageal Reflux Following  Anti-Reflux Surgery. Presented (Oral  Presentation) at Society of Thoracic Surgeons Annual Meeting, San Diego, CA Jan 2007

  • Pennathur A, Abbas G, Luketich JD et al.  Stereotactic Radio Surgery For The Treatment Of Non-Small Cell Lung Cancer. International Symposium on Regional Cancer Therapies, San Juan, Puerto Rico, February 24-26, 2007.

  • Pennathur A, Luketich JD, Abbas G et al. Radiofrequency Ablation for the Treatment of Non-Small Cell Lung Neoplasm. International Symposium on Regional Cancer Therapies, San Juan, Puerto Rico, February 24-26, 2007.

  • Pennathur A,  Luketich JD, Burton S et al. Stereotactic Radio Surgery For TheTreatment of Stage I Non-small Cell Lung cancer In High-Risk Patients.  Presented (Oral Presentation)at American Association for Thoracic Surgery(AATS) Annual  Meeting.Washington DC, May 5-9 2007

  • Pennathur A, Abbas G, Gooding WE et al.. Radiofrequency Ablation for the Treatment of Stage I Non-small Cell Lung Cancer in High-Risk Patients. Presented at 15th Spore Investigator’s Workshop, Baltimore, MD July 7-10 2007

  • Pennathur A, Alvelo – Rivera M, Farkas A et al. T1 Esophageal Cancer: An Analysis of Outcomes of Esophagectomy in 100 Consecutive Patients and Implications in an Era of Emerging Endoscopic Therapies. Presented (Oral Presentation) at Southern Thoracic Surgical Association (STSA) 54th Annual Meeting, Bonita Springs FL November 08-10, 20

  • Pennathur A, Christie NA, Ferson P et al.Surgical Resection IsJustified In Non Small Cell Lung  Cancer Patients With Node Negative T4 Satellite Lesions. Presented (Oral Presentation) at Southern Thoracic  Surgical Association (STSA) 54th Annual  Meeting, Bonita Springs FL, November 08-10, 2007 

  • Pennathur A, Abbas G, Wang Y et al. Radiofrequency Ablation for the Treatment of Pulmonary Metastases. Presented (Oral Presentation) at Southern Thoracic Surgical  Association (STSA) 54th Annual Meeting, Bonita Springs FL November 08-10, 2007